Richard Colvin
Chief Tech/Sci/R&D Officer at BLUEBIRD BIO, INC.
Net worth: 151 511 $ as of 2024-03-30
Profile
Richard Colvin is currently the Chief Medical Officer at bluebird bio, Inc. He previously worked as an Executive Director-Translational Medicine at Novartis, Inc. Dr. Colvin completed his undergraduate degree at Cornell University and obtained a doctorate from Duke University School of Medicine.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
BLUEBIRD BIO, INC.
0.06% | 2024-02-29 | 118,368 ( 0.06% ) | 151 511 $ | 2024-03-30 |
Richard Colvin active positions
| Companies | Position | Start |
|---|---|---|
| BLUEBIRD BIO, INC. | Chief Tech/Sci/R&D Officer | 2021-02-28 |
Former positions of Richard Colvin
| Companies | Position | End |
|---|---|---|
Novartis, Inc.
 Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Corporate Officer/Principal | - |
Training of Richard Colvin
| Cornell University | Undergraduate Degree |
| Duke University School of Medicine | Doctorate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| BLUEBIRD BIO, INC. | Health Technology |
| Private companies | 1 |
|---|---|
Novartis, Inc.
Novartis, Inc. Pharmaceuticals: MajorHealth Technology Part of Novartis AG, Novartis, Inc. is a private company based in San Francisco. | Health Technology |
- Stock Market
- Insiders
- Richard Colvin
